Company news
Jointown Pharmaceutical Group Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs
May 6, 2026
Announcement on Holding Subsidiary Certified as High-tech Enterprise
April 29, 2026
Report for Q1 2026
April 27, 2026
Announcement on Results of Issuing Phase II Ultra-Short-Term Financing Bonds of 2026
April 23, 2026
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Azelastine Hydrochloride Nasal Spray
April 21, 2026
Announcement on Temporary Idle Funds’ Investment Management Arrangements for Q1 2026
April 8, 2026
Announcement on Receipt of the "Notice of Registration Acceptance" from the National Association of Financial Market Institutional Investors
April 2, 2026
Announcement on Obtaining Medical Device Registration Certificate by Holding Subsidiary
March 24, 2026
Announcement on the Results of Issuance of the 2026 Phase II Science and Technology Innovation Bonds
March 11, 2026
Announcement on Advance Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in Concert
February 10, 2026
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride Tablets
February 6, 2026
Announcement on Completion of Industrial and Commercial Change Registration and Filing of Articles of Association
January 22, 2026
Announcement on the Results of Issuance of the 2026 Phase I Science and Technology Innovation Bonds
January 21, 2026
Announcement on Entrusted Financial Management in Q4 2025
January 16, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
January 7, 2026
Announcement on Obtaining Drug Registration Certificate for Bupivacaine Hydrochloride Injection
January 6, 2026
Announcement on Provision of Online Voting Reminder Service for General Meeting
January 4, 2026
Announcement on Early Release of Pledge and Pledge of Shareholders' Shares
December 30, 2025
Announcement on Completion of Execution of Reorganization Plan of Aoyuan Beauty Valley Technology Co., Ltd., in Which the Wholly-owned Subsidiary Participated as a Reorganization Investor
December 29, 2025
Announcement on Obtaining Drug Registration Certificate for Isopropylamine Hydrochloride Injection
December 26, 2025
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase III) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration
December 23, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2026
December 19, 2025
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase II) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration
December 17, 2025
Announcement on Issuance of the Phase I Asset-backed Notes for 2025 and Related Party Transactions
November 21, 2025
Announcement on Progress in Court's Acceptance of the Reorganization and Appointment of a Administrator for Aoyuan Meigu Technology Co., Ltd., a Wholly-owned Subsidiary Participating in the Reorganization Investment
November 16, 2025
Announcement on Pledge of Shareholders' Shares
November 13, 2025
Announcement on Completion of Filing for Industrial Fund Established by Holding Grandchild Subsidiary
November 11, 2025
Announcement on Outline of the Q3 2025 Performance Briefing
November 4, 2025
Announcement on Resolutions of the 17th Meeting of the 6th Board of Directors
October 27, 2025
Announcement on Entrusted Financial Management in Q3 2025
October 14, 2025
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase I) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust Registration
October 10, 2025
Announcement on Early Release of Pledge of Shareholders' Shares
September 26, 2025
Announcement on Participating in the Establishment of Industrial Fund and Related Party Transactions
September 22, 2025
Announcement on Outline of the 2025 Semi-annual Performance Briefing
September 3, 2025
Announcement on Resolutions of the 16th Meeting of the 6th Board of Directors
August 26, 2025
Announcement on Upgrading Subject Credit Rating to AAA
August 25, 2025
Announcement on Expiration of Duration and Termination of Phase III Employee Stock Ownership Plan in 2022
July 21, 2025
Announcement on Entrusted Financial Management in Q2 2025
July 16, 2025
Announcement on the Completion of Filing for the Industry Fund Established by Wholly-Owned Subsidiary
July 4, 2025
Announcement on Obtaining Drug Registration Certificate for Dexamethasone Sodium Phosphate Injection
June 20, 2025